CYAD

Celyad Oncology S.A. CYAD

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CYAD IMNN SQZB REUN AXLA KA TLPH ATON HURA GLS
6M -52.53 % -63.77 % -17.86 % 5.16 % 0.00 % 18.21 % 150.51 % -49.95 % -34.95 % -43.56 %
YTD -6.00 % -71.11 % -23.33 % 7.69 % 0.00 % -83.10 % 127.08 % 5.33 % -37.96 % -69.50 %
1Y -74.18 % -69.05 % 0.00 % -69.61 % 0.00 % -83.49 % 50.67 % 2.59 % -53.47 % -96.44 %
3Y -96.18 % -79.64 % -99.19 % -88.58 % -89.71 % -98.76 % -40.97 % -96.36 % -50.96 % -98.39 %
5Y -98.23 % -95.70 % -99.84 % -88.58 % -96.03 % -99.28 % -96.34 % -97.14 % -96.11 % -98.39 %
10Y -99.14 % -99.92 % -99.83 % -88.58 % -98.67 % -99.92 % -98.47 % -98.16 % -99.89 % -98.39 %
From the beginning -99.14 % -100.00 % -99.83 % -88.58 % -98.67 % -99.92 % -98.53 % -97.66 % -99.93 % -98.39 %

Dividend

Kineta, Inc.